SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-026049
Filing Date
2017-04-26
Accepted
2017-04-26 06:03:15
Documents
67
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a17-8898_110q.htm 10-Q 1057723
2 EX-10.1 a17-8898_1ex10d1.htm EX-10.1 32227
3 EX-31.1 a17-8898_1ex31d1.htm EX-31.1 12900
4 EX-31.2 a17-8898_1ex31d2.htm EX-31.2 12904
5 EX-32.1 a17-8898_1ex32d1.htm EX-32.1 7428
6 EX-32.2 a17-8898_1ex32d2.htm EX-32.2 7439
  Complete submission text file 0001104659-17-026049.txt   5573672

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT uthr-20170331.xml EX-101.INS 1213191
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20170331.xsd EX-101.SCH 49321
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20170331_cal.xml EX-101.CAL 61017
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20170331_def.xml EX-101.DEF 206100
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT uthr-20170331_lab.xml EX-101.LAB 461969
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20170331_pre.xml EX-101.PRE 343787
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 17782410
SIC: 2834 Pharmaceutical Preparations